secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2026-06-16T20:15:07+00:00
Accession:  0001567264-26-000049
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics stockholders elect directors, approve equity plan amendments at annual meeting
--------------------------------------------------------------------------------

- Elected Dr. Emer Leahy and Lewis H. Bender as Class III directors with ~416,613 and ~422,149 votes for, respectively.
- Ratified EisnerAmper LLP as auditor for FY 2026 with 1,024,971 votes for, 4,852 against.
- Approved amendment to 2021 Stock Incentive Plan to increase shares by 150,000 (363,563 for, 69,252 against).
- Approved amendment to 2024 ESPP to increase shares by 25,000 (407,404 for, 25,350 against).
- Adjournment proposal passed with 939,304 votes for, 126,814 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/0001567264-26-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/intensity-20260616.htm
  HTML page:      https://secwatch.observer/filing/0001567264-26-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer